Biocon Biologics
Peter Fields has had an extensive career in pharmaceutical sales and management. Peter currently serves as the Head of Sales, Canada at Biocon Biologics. Prior to this role, Peter held positions at Viatris and Merck, where Peter specialized in oncology sales and marketing. Throughout their career, Peter has successfully developed and executed strategies for various pharmaceutical products, including KEYTRUDA and LYNPARZA. Peter's expertise also extends to key account management, institutional strategy, and public health policy. Peter has a strong educational background, having studied at the University of Waterloo and the Council for Continuing Pharmaceutical Education.
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics